Clinical trial · Observational
A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab
Nivolumab in the Treatment of Patients With Non-small Cell Lung Cancer: The Australian Experience
NCT03804554CI-TRIAL-00058758completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is to capture and describe the patient and disease characteristics and the outcomes of adult patients with previously-treated advanced NSCLC who have been treated with Nivolumab
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non-Interventional | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients taking nivolumab
- interventionNames
- Other: Non-Interventional
Primary outcomes (1)
- measure
- Time to treatment failure (TTF)
- timeFrame
- Approximately 27 months
Secondary outcomes (8)
- measure
- Best overall response (BOR)
- timeFrame
- Approximately 27 months
- measure
- Progression free survival rate (PFSR)
- timeFrame
- Approximately 27 months
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria * Adult male or female (≥18 years of age) patients with NSCLC * Treated with nivolumab on the Australian PAP * Initiated Nivolumab between May 2015 and August 2017 * Attending clinician agreeable to provide patient data * Local institutional ethics requirements satisfied Exclusion Criteria: * Insufficient data available Other protocol defined inclusion/exclusion criteria could apply
References
Publications (0)
Data not yet available
No reference posted for this study.